Champions Oncology (CSBR) Retained Earnings (2011 - 2026)

Champions Oncology (CSBR) has 16 years of Retained Earnings data on file, last reported at -$81.5 million in Q3 2026.

• On a quarterly basis, Retained Earnings fell 1.37% year-over-year to -$81.5 million in Q3 2026; TTM through Jul 2026 was -$81.5 million, a 1.37% decrease from a year earlier, with the FY2026 full-year figure at -$81.1 million, down 1.47% from the prior year.
• Retained Earnings for Q3 2026 stood at -$81.5 million, down from -$81.1 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$71.6 million in Q1 2022 and bottomed at -$84.6 million in Q2 2024.
• Historically, Retained Earnings has averaged -$78.9 million across 5 years, with a median of -$80.1 million in 2025.
• The widest annual swing landed in 2023, when Retained Earnings slipped 13.39%; it then advanced 7.57% in 2025.
• Year by year, Retained Earnings stood at -$72.3 million in 2022, then dropped by 13.39% to -$82.0 million in 2023, then slipped by 0.73% to -$82.6 million in 2024, then climbed by 3.0% to -$80.1 million in 2025, then decreased by 1.72% to -$81.5 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$81.5 million in Q3 2026, -$81.1 million in Q2 2026, and -$80.4 million in Q1 2026.